Reaction

Bronchial Wall Thickening reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 716 reports · 48 co-occurring drugs

As of the last recalculation, Bronchial Wall Thickening appears in 716 FAERS reports alongside 48 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 408.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Ciclesonide	151	408.1	412.7
Theophylline Anhydrous	98	266.1	268.2
Theophylline	89	256.9	258.9
Fluticasone Furoate And Vilanterol Trifenatate	147	149.2	149.9
Tamsulosin Hydrochloride	67	105.2	105.5
Mepolizumab	136	98.0	98.3
Tiotropium Bromide	248	80.0	80.1
Montelukast Sodium	219	74.9	75.0
Mometasone Furoate	76	59.2	59.3
Albuterol	177	56.6	56.7
Benralizumab	36	55.0	55.1
Albuterol Sulfate	298	49.3	49.3
Finasteride	88	48.2	48.3
Ipratropium Bromide	49	42.8	42.8
Tiotropium Bromide Inhalation Spray	16	42.4	42.5
Olmesartan Medoxomil	48	41.5	41.6
Umeclidinium	12	39.6	39.7
Nicotine Polacrilex Mini	19	37.8	37.8
Nicotine Polarilex	19	37.8	37.8
Montelukast	90	35.5	35.5
Apixaban	73	35.2	35.2
Azithromycin	44	33.8	33.8
Loperamide Hydrochloride And Dimethicone	35	33.3	33.3
Azithromycin Monohydrate	44	32.6	32.7
Mometasone	20	32.6	32.6
Budesonide And Formoterol Fumarate Dihydrate	94	32.3	32.3
Hydroxyzine Hydrochloride	13	29.2	29.3
Hydroxyzine Hydrochloride Oral	13	29.2	29.3
Omalizumab	75	28.5	28.5
Indapamide	17	28.2	28.2
Tobramycin Solution	11	27.0	27.0
Fluticasone Propionate And Salmeterol Xinafoate	51	26.5	26.5
Tobramycin Sulfate	11	26.2	26.2
Azithromycin Dihydrate	46	24.3	24.3
Loperamide Hydrochloride	35	23.9	23.9
Bisoprolol Fumarate	96	23.6	23.6
Tobramycin	19	23.6	23.6
Hydroxyzine	35	22.4	22.4
Dornase Alfa	11	16.5	16.6
Mirabegron	20	15.4	15.4
Nicotine Polacrilex	19	14.8	14.8
Nicotine	20	14.8	14.8
Desoximetasone	9	13.9	13.9
Lumacaftor And Ivacaftor	4	13.6	13.6
Canakinumab	4	10.8	10.8
Mometasone Furoate And Formoterol Fumarate Dihydrate	5	9.4	9.4
Salicylic Acid	15	8.4	8.4
Blinatumomab	3	8.4	8.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.